In-person clinical trials have been essential for medical researchers. Participants would travel to hospitals or research centers, fill out paperwork, and meet one-on-one with clinicians — until the coronavirus pandemic impeded those efforts. Many clinical trials have since become virtual, which may be considered advantageous, as more people can partake without the hassles. In fact, Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, believes online trials may be here to stay. To read the full story.
Recent Posts
- Study Finds Widespread Exposure to Hormone-Disrupting Chemical During Pregnancy.
- Community-Based Programs in Senior Centers May Lower Health Care Use and Costs for People with Dementia
- New NJACTS Publication
- How Rutgers Health and Vaccine Equity Education Coalition Ambassadors at the Boys & Girls Club of Newark Are Promoting Vaccine Equity.
- Center for Environmental Exposures and Disease 7th Annual Environmental Health and Justice Summit 10/18, 9am-4pm
Categories
- Community (2,020)
- Covid (975)
- CTO Events (3)
- News (2,570)
- Pilots (20)